Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrations.
Karen Louise JonesLian Q HuynhSeva HatzinikolasRachael S RigdaLiza K PhillipsHung T PhamChinmay S MaratheChinmay S MaratheCharles H MalbertJulie E StevensKylie LangeChristopher K RaynerMichael HorowitzPublished in: Diabetes, obesity & metabolism (2020)
In healthy participants, 8 weeks' administration of the "long-acting" glucagon-like peptide-1 receptor agonist EXE, slowed gastric emptying of solids and liquids substantially, with consequent reductions in glucose absorption and postprandial glycaemia.